Effects of DHA on cognitive dysfunction in aging and Alzheimer's disease: The mediating roles of ApoE

Feng, 2021, Current research status of blood biomarkers in Alzheimer’s disease: diagnosis and prognosis, Ageing Res Rev, 72, 10.1016/j.arr.2021.101492

Rafii, 2020, The search for Alzheimer disease therapeutics—same targets, better trials?, Nat Rev Neurol, 16, 597, 10.1038/s41582-020-00414-3

van der Lee, 2018, The effect of APOE and other common genetic variants on the onset of Alzheimer’s disease and dementia: a community-based cohort study, Lancet Neurol, 17, 434, 10.1016/S1474-4422(18)30053-X

Baranowski, 2020, Healthy brain, healthy life: a review of diet and exercise interventions to promote brain health and reduce Alzheimer’s disease risk, Appl Physiol Nutr Metab, 45, 1055, 10.1139/apnm-2019-0910

Yassine, 2020, APOE alleles and diet in brain aging and Alzheimer’s disease, Front Aging Neurosci, 12, 150, 10.3389/fnagi.2020.00150

Mahan, 2022, Selective reduction of astrocyte apoE3 and apoE4 strongly reduces Aβ accumulation and plaque-related pathology in a mouse model of amyloidosis, Mol Neurodegener, 17, 13, 10.1186/s13024-022-00516-0

Yamazaki, 2019, Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies, Nat Rev Neurol, 15, 501, 10.1038/s41582-019-0228-7

Carvalho-Wells, 2012, APOE genotype influences triglyceride and C-reactive protein responses to altered dietary fat intake in UK adults, Am J Clin Nutr, 96, 1447, 10.3945/ajcn.112.043240

Rebeck, 2017, The role of APOE on lipid homeostasis and inflammation in normal brains, J Lipid Res, 58, 1493, 10.1194/jlr.R075408

Angelopoulou, 2021, APOE genotype and Alzheimer’s disease: the influence of lifestyle and environmental factors, ACS Chem Nerosci, 12, 2749, 10.1021/acschemneuro.1c00295

Cao, 2016, Dietary patterns and risk of dementia: a systematic review and meta-analysis of cohort studies, Mol Neurobiol, 53, 6144, 10.1007/s12035-015-9516-4

Yusufov, 2017, Alzheimer’s disease and diet: a systematic review, Int J Neurosci, 127, 161, 10.3109/00207454.2016.1155572

Zhang, 2015, Intakes of fish and polyunsaturated fatty acids and mild-to-severe cognitive impairment risks: a dose-response meta-analysis of 21 cohort studies–3, Am J Clin Nutr, 103, 330, 10.3945/ajcn.115.124081

Power, 2019, The role of nutrition for the aging population: implications for cognition and Alzheimer’s disease, Annu Rev Food Sci Technol, 10, 619, 10.1146/annurev-food-030216-030125

Lacombe, 2018, Brain docosahexaenoic acid uptake and metabolism, Mol Aspects Med, 64, 109, 10.1016/j.mam.2017.12.004

Chappus-McCendie, 2019, Omega-3 PUFA metabolism and brain modifications during aging, Prog Neuropsychopharmacol Biol Psychiatry, 94, 10.1016/j.pnpbp.2019.109662

Zhang, 2020, Advances in exogenous docosahexaenoic acid-containing phospholipids: sources, positional isomerism, biological activities, and advantages, Compr Rev Food Sci Food Saf, 19, 1420, 10.1111/1541-4337.12543

Yassine, 2017, Association of docosahexaenoic acid supplementation with Alzheimer disease stage in apolipoprotein E ε4 carriers: a review, JAMA Neurol, 74, 339, 10.1001/jamaneurol.2016.4899

Salem, 2015, The benefit of docosahexaenoic acid for the adult brain in aging and dementia, Prostaglandins Leukot Essent Fatty Acids, 92, 15, 10.1016/j.plefa.2014.10.003

Quinn, 2010, Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial, JAMA, 304, 1903, 10.1001/jama.2010.1510

Jack, 2018, NIA-AA research framework: toward a biological definition of Alzheimer’s disease, Alzheimers Dement, 14, 535, 10.1016/j.jalz.2018.02.018

Freer, 2016, A protein homeostasis signature in healthy brains recapitulates tissue vulnerability to Alzheimer’s disease, Sci Adv, 2, 10.1126/sciadv.1600947

Brier, 2016, N-methyl-D-aspartate receptor encephalitis mediates loss of intrinsic activity measured by functional MRI, J Neurol, 263, 1083, 10.1007/s00415-016-8083-6

Rhodius-Meester, 2019, Survival in memory clinic cohort is short, even in young-onset dementia, J Neurol Neurosurg Psychiatry, 90, 726, 10.1136/jnnp-2018-318820

Cunnane, 2009, Fish, docosahexaenoic acid and Alzheimer’s disease, Prog Lipid Res, 48, 239, 10.1016/j.plipres.2009.04.001

Bishop, 2010, Neural mechanisms of ageing and cognitive decline, Nature, 464, 529, 10.1038/nature08983

Tzioras, 2023, Synaptic degeneration in Alzheimer disease, Nat Rev Neurol, 19, 19, 10.1038/s41582-022-00749-z

Lin, 2020, Contributions of DNA damage to Alzheimer’s disease, Int J Mol Sci, 21, 1666, 10.3390/ijms21051666

He, 2013, Amyloid-β1–42 oligomer accelerates senescence in adult hippocampal neural stem/progenitor cells via formylpeptide receptor 2, Cell Death Dis, 4, 10.1038/cddis.2013.437

Bussian, 2018, Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline, Nature, 562, 578, 10.1038/s41586-018-0543-y

Andrade-Guerrero, 2023, Alzheimer’s disease: an updated overview of its genetics, Int J Mol Sci, 24, 3754, 10.3390/ijms24043754

Hampel, 2021, The amyloid-β pathway in Alzheimer’s disease, Mol Psychiatry, 26, 5481, 10.1038/s41380-021-01249-0

Schellenberg, 2012, The genetics and neuropathology of Alzheimer’s disease, Acta Neuropathol, 124, 305, 10.1007/s00401-012-0996-2

Henry, 2018, Lipidated apolipoprotein E4 structure and its receptor binding mechanism determined by a combined cross-linking coupled to mass spectrometry and molecular dynamics approach, PLoS Comput Biol, 14, 10.1371/journal.pcbi.1006165

Sah, 2017, Effect of high-fat diet on cognitive impairment in triple-transgenic mice model of Alzheimer’s disease, Biochem Biophys Res Commun, 493, 731, 10.1016/j.bbrc.2017.08.122

Husain, 2021, APOE and Alzheimer’s disease: from lipid transport to physiopathology and therapeutics, Front Neurosci, 15, 10.3389/fnins.2021.630502

Troutwine, 2022, Apolipoprotein E and Alzheimer’s disease, Acta Pharm Sin B, 12, 496, 10.1016/j.apsb.2021.10.002

Sando, 2008, APOE ε4 lowers age at onset and is a high risk factor for Alzheimer’s disease; a case control study from Central Norway, BMC Neurol, 8, 1, 10.1186/1471-2377-8-9

Riching, 2019, The brain–heart axis: alzheimer’s, diabetes, and hypertension, ACS Pharmacol Transl Sci, 3, 21, 10.1021/acsptsci.9b00091

Hoscheidt, 2022, Mediterranean and Western diet effects on Alzheimer’s disease biomarkers, cerebral perfusion, and cognition in mid-life: a randomized trial, Alzheimers Dement, 18, 457, 10.1002/alz.12421

Profenno, 2010, Meta-analysis of Alzheimer’s disease risk with obesity, diabetes, and related disorders, Biol Psychiatry, 67, 505, 10.1016/j.biopsych.2009.02.013

Emma, 2022, Dietary lipids from body to brain, Prog Lipid Res, 85

Shahidi, 2018, Omega-3 polyunsaturated fatty acids and their health benefits, Annu Rev Food Sci Technol, 9, 345, 10.1146/annurev-food-111317-095850

Hosseini, 2020, Blood fatty acids in Alzheimer’s disease and mild cognitive impairment: a meta-analysis and systematic review, Ageing Res Rev, 60, 10.1016/j.arr.2020.101043

Sambra, 2021, Docosahexaenoic and arachidonic acids as neuroprotective nutrients throughout the life cycle, Nutrients, 13, 986, 10.3390/nu13030986

Zhang, 2019, Health benefits of dietary marine DHA/EPA-enriched glycerophospholipids, Prog Lipid Res, 75, 10.1016/j.plipres.2019.100997

Weiser, 2016, Docosahexaenoic acid and cognition throughout the lifespan, Nutrients, 8, 99, 10.3390/nu8020099

Igarashi, 2010, Brain lipid concentrations in bipolar disorder, J Psychiatr Res, 44, 177, 10.1016/j.jpsychires.2009.08.001

Balakrishnan, 2021, Structured form of DHA prevents neurodegenerative disorders: a better insight into the pathophysiology and the mechanism of DHA transport to the brain, Nutr Res, 85, 119, 10.1016/j.nutres.2020.12.003

Brenna, 2022, New understandings of the pathway of long-chain polyunsaturated fatty acid biosynthesis, Curr Opin Clin Nutr Metab Care, 25, 60, 10.1097/MCO.0000000000000810

Kothapalli, 2020, Polyunsaturated fatty acid biosynthesis pathway and genetics. Implications for interindividual variability in prothrombotic, inflammatory conditions such as COVID-19(✰,✰✰,★,★★), Prostaglandins Leukot Essent Fatty Acids, 162, 10.1016/j.plefa.2020.102183

Skorve, 2015, Fish oil and krill oil differentially modify the liver and brain lipidome when fed to mice, Lipids Health Dis, 14, 1, 10.1186/s12944-015-0086-2

Kagan, 2015, Comparative study of tissue deposition of omega-3 fatty acids from polar-lipid rich oil of the microalgae Nannochloropsis oculata with krill oil in rats, Food Funct, 6, 185, 10.1039/C4FO00591K

Chevalier, 2021, Comparison of pharmacokinetics of omega-3 fatty acid supplements in monoacylglycerol or ethyl ester in humans: a randomized controlled trial, Eur J Clin Nutr, 75, 680, 10.1038/s41430-020-00767-4

Kitson, 2016, Effect of dietary docosahexaenoic acid (DHA) in phospholipids or triglycerides on brain DHA uptake and accretion, J Nutr Biochem, 33, 91, 10.1016/j.jnutbio.2016.02.009

Pan, 1821, Gut triglyceride production, Biochim Biophys Acta, 2012, 727

Zhang, 2023, The gut microbiota-artery axis: a bridge between dietary lipids and atherosclerosis?, Prog Lipid Res, 89, 10.1016/j.plipres.2022.101209

Galli, 1992, Prolonged retention of doubly labeled phosphatidylcholine in human plasma and erythrocytes after oral administration, Lipids, 27, 1005, 10.1007/BF02535580

Lagarde, 2001, Lysophosphatidylcholine as a preferred carrier form of docosahexaenoic acid to the brain, J Mol Neurosci, 16, 201, 10.1385/JMN:16:2-3:201

Liu, 2014, Higher efficacy of dietary DHA provided as a phospholipid than as a triglyceride for brain DHA accretion in neonatal piglets, J Lipid Res, 55, 531, 10.1194/jlr.M045930

Thies, 1994, Preferential incorporation of sn-2 lysoPC DHA over unesterified DHA in the young rat brain, Am J Physiol, 267, R1273

Zhao, 2015, Establishment and dysfunction of the blood-brain barrier, Cell, 163, 1064, 10.1016/j.cell.2015.10.067

Chen, 2008, Regulation of brain polyunsaturated fatty acid uptake and turnover, Prostaglandins Leukot Essent Fatty Acids, 79, 85, 10.1016/j.plefa.2008.09.003

Bazinet, 2019, How the plasma lysophospholipid and unesterified fatty acid pools supply the brain with docosahexaenoic acid, Prostaglandins Leukot Essent Fatty Acids, 142, 1, 10.1016/j.plefa.2018.12.003

Zhao, 2014, Blood-brain barrier: a dual life of MFSD2A?, Neuron, 82, 728, 10.1016/j.neuron.2014.05.012

Chen, 2015, Plasma non-esterified docosahexaenoic acid is the major pool supplying the brain, Sci Rep, 5, 15791, 10.1038/srep15791

Chen, 2008, The low density lipoprotein receptor is not necessary for maintaining mouse brain polyunsaturated fatty acid concentrations, J Lipid Res, 49, 147, 10.1194/jlr.M700386-JLR200

Pan, 2015, Fatty acid-binding protein 5 facilitates the blood–brain barrier transport of docosahexaenoic acid, Mol Pharm, 12, 4375, 10.1021/acs.molpharmaceut.5b00580

Nguyen, 2014, Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid, Nature, 509, 503, 10.1038/nature13241

Cardoso, 2016, Dietary DHA and health: cognitive function ageing, Nutr Res Rev, 29, 281, 10.1017/S0954422416000184

Chu, 2022, Higher serum DHA and slower cognitive decline in patients with Alzheimer’s disease: two-year follow-up, Nutrients, 14, 1159, 10.3390/nu14061159

Morris, 2003, Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease, Arch Neurol, 60, 940, 10.1001/archneur.60.7.940

Johnson, 2008, Cognitive findings of an exploratory trial of docosahexaenoic acid and lutein supplementation in older women, Nutr Neurosci, 11, 75, 10.1179/147683008X301450

Witte, 2014, Long-chain omega-3 fatty acids improve brain function and structure in older adults, Cereb Cortex, 24, 3059, 10.1093/cercor/bht163

Malik, 2021, ω-3 Ethyl ester results in better cognitive function at 12 and 30 months than control in cognitively healthy subjects with coronary artery disease: a secondary analysis of a randomized clinical trial, Am J Clin Nutr, 113, 1168, 10.1093/ajcn/nqaa420

Geleijnse, 2012, Effects of n-3 fatty acids on cognitive decline: a randomized, double-blind, placebo-controlled trial in stable myocardial infarction patients, Alzheimers Dement, 8, 278, 10.1016/j.jalz.2011.06.002

Balachandar, 2020, Docosahexaenoic acid supplementation in age-related cognitive decline: a systematic review and meta-analysis, Eur J Clin Pharmacol, 76, 639, 10.1007/s00228-020-02843-x

Danthiir, 2018, An 18-mo randomized, double-blind, placebo-controlled trial of DHA-rich fish oil to prevent age-related cognitive decline in cognitively normal older adults, Am J Clin Nutr, 107, 754, 10.1093/ajcn/nqx077

van de Rest, 2008, Effect of fish oil on cognitive performance in older subjects: a randomized, controlled trial, Neurology, 71, 430, 10.1212/01.wnl.0000324268.45138.86

Dangour, 2010, Effect of 2-y n-3 long-chain polyunsaturated fatty acid supplementation on cognitive function in older people: a randomized, double-blind, controlled trial, Am J Clin Nutr, 91, 1725, 10.3945/ajcn.2009.29121

Yurko-Mauro, 2010, Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline, Alzheimers Dement, 6, 456, 10.1016/j.jalz.2010.01.013

Li, 2021, Effect of folic acid combined with docosahexaenoic acid intervention on mild cognitive impairment in elderly: a randomized double-blind, placebo-controlled trial, Eur J Nutr, 60, 1795, 10.1007/s00394-020-02373-3

Lee, 2013, Docosahexaenoic acid-concentrated fish oil supplementation in subjects with mild cognitive impairment (MCI): a 12-month randomised, double-blind, placebo-controlled trial, Psychopharmacology, 225, 605, 10.1007/s00213-012-2848-0

Zhang, 2018, DHA supplementation improves cognitive function via enhancing Aβ-mediated autophagy in Chinese elderly with mild cognitive impairment: a randomised placebo-controlled trial, J Neurol Neurosurg Psychiatry, 89, 382, 10.1136/jnnp-2017-316176

Baleztena, 2018, Association between cognitive function and supplementation with omega-3 PUFAs and other nutrients in ≥ 75 years old patients: a randomized multicenter study, PloS One, 13, 10.1371/journal.pone.0193568

Kotani, 2006, Dietary supplementation of arachidonic and docosahexaenoic acids improves cognitive dysfunction, Neurosci Res, 56, 159, 10.1016/j.neures.2006.06.010

Chiu, 2008, The effects of omega-3 fatty acids monotherapy in Alzheimer’s disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study, Prog Neuropsychopharmacol Biol Psychiatry, 32, 1538, 10.1016/j.pnpbp.2008.05.015

Phillips, 2015, No effect of omega-3 fatty acid supplementation on cognition and mood in individuals with cognitive impairment and probable Alzheimer’s disease: a randomised controlled trial, Int J Mol Sci, 16, 24600, 10.3390/ijms161024600

Soininen, 2017, 24-month intervention with a specific multinutrient in people with prodromal Alzheimer’s disease (LipiDiDiet): a randomised, double-blind, controlled trial, Lancet Neurol, 16, 965, 10.1016/S1474-4422(17)30332-0

Stonehouse, 2013, DHA supplementation improved both memory and reaction time in healthy young adults: a randomized controlled trial, Am J Clin Nutr, 97, 1134, 10.3945/ajcn.112.053371

Huang, 2005, Benefits of fatty fish on dementia risk are stronger for those without APOE ε4, Neurology, 65, 1409, 10.1212/01.wnl.0000183148.34197.2e

Barberger-Gateau, 2007, Dietary patterns and risk of dementia: the Three-City cohort study, Neurology, 69, 1921, 10.1212/01.wnl.0000278116.37320.52

Whalley, 2008, n–3 Fatty acid erythrocyte membrane content, APOE ε4, and cognitive variation: an observational follow-up study in late adulthood, Am J Clin Nutr, 87, 449, 10.1093/ajcn/87.2.449

Hashimoto, 2017, Docosahexaenoic acid: one molecule diverse functions, Crit Rev Biotechnol, 37, 579, 10.1080/07388551.2016.1207153

Papadopoulos, 2022, Structural determinant of β-amyloid formation: from transmembrane protein dimerization to β-amyloid aggregates, Biomedicines, 10, 2753, 10.3390/biomedicines10112753

Haass, 2012, Trafficking and proteolytic processing of APP, Cold Spring Harb Perspect Med, 2, 10.1101/cshperspect.a006270

Zhao, 2011, Docosahexaenoic acid-derived neuroprotectin D1 induces neuronal survival via secretase-and PPARγ-mediated mechanisms in Alzheimer’s disease models, PloS One, 6

Van Gool, 2019, LRP1 has a predominant role in production over clearance of Aβ in a mouse model of Alzheimer’s disease, Mol Neurobiol, 56, 7234, 10.1007/s12035-019-1594-2

Bie, 2021, Protective effect and mechanism of docosahexaenoic acid on the cognitive function in female APP/PS1 mice, Food Funct, 12, 11435, 10.1039/D1FO01922H

Hashimoto, 2008, Docosahexaenoic acid disrupts in vitro amyloid β1-40 fibrillation and concomitantly inhibits amyloid levels in cerebral cortex of Alzheimer’s disease model rats, J Neurochem, 107, 1634, 10.1111/j.1471-4159.2008.05731.x

Dixit, 2008, Differential regulation of dynein and kinesin motor proteins by tau, Science, 319, 1086, 10.1126/science.1152993

Giannakopoulos, 2003, Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer’s disease, Neurology, 60, 1495, 10.1212/01.WNL.0000063311.58879.01

Zgórzyńska, 2021, Docosahexaenoic fatty acid reduces the pro-inflammatory response induced by IL-1β in astrocytes through inhibition of NF-κB and AP-1 transcription factor activation, BMC Neurosci, 22, 1, 10.1186/s12868-021-00611-w

Bazan, 2011, Docosahexaenoic acid signalolipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration, Alzheimer’s, and other neurodegenerative diseases, Annu Rev Nutr, 31, 321, 10.1146/annurev.nutr.012809.104635

Lukiw, 2005, A role for docosahexaenoic acid–derived neuroprotectin D1 in neural cell survival and Alzheimer disease, J Clin Invest, 115, 2774, 10.1172/JCI25420

Schwab, 2007, Resolvin E1 and protectin D1 activate inflammation-resolution programmes, Nature, 447, 869, 10.1038/nature05877

Li, 2020, Role of resolvins in the inflammatory resolution of neurological diseases, Front Pharmacol, 11, 612, 10.3389/fphar.2020.00612

Chataigner, 2021, Fish hydrolysate supplementation containing n-3 long chain polyunsaturated fatty acids and peptides prevents LPS-induced neuroinflammation, Nutrients, 13, 10.3390/nu13030824

Vedin, 2008, Effects of docosahexaenoic acid-rich n-3 fatty acid supplementation on cytokine release from blood mononuclear leukocytes: the OmegAD study, Am J Clin Nutr, 87, 1616, 10.1093/ajcn/87.6.1616

Olufunmilayo, 2023, Oxidative stress and antioxidants in neurodegenerative disorders, Antioxidants, 12, 517, 10.3390/antiox12020517

Poprac, 2017, Targeting free radicals in oxidative stress-related human diseases, Trends Pharmacol Sci, 38, 592, 10.1016/j.tips.2017.04.005

Cm, 2018, Oxidative stress and the amyloid beta peptide in Alzheimer’s disease, Redox Biol, 14, 450, 10.1016/j.redox.2017.10.014

Green, 2001, Enhanced free radical scavenging and decreased lipid peroxidation in the rat fetal brain after treatment with ethyl docosahexaenoate, Biochim Biophys Acta Mol Cell Biol Lipids, 1532, 203, 10.1016/S1388-1981(01)00132-9

Hashimoto, 2002, Docosahexaenoic acid provides protection from impairment of learning ability in Alzheimer’s disease model rats, J Neurochem, 81, 1084, 10.1046/j.1471-4159.2002.00905.x

Xu, 2023, Docosahexaenoic acid enhances hippocampal insulin sensitivity to promote cognitive function of aged rats on a high-fat diet, J Adv Res, 45, 31, 10.1016/j.jare.2022.04.015

Lee, 2013, The role of long chain omega-3 polyunsaturated fatty acids in reducing lipid peroxidation among elderly patients with mild cognitive impairment: a case-control study, J Nutr Biochem, 24, 803, 10.1016/j.jnutbio.2012.04.014

Goodenowe, 2022, Targeted plasmalogen supplementation: effects on blood plasmalogens, oxidative stress biomarkers, cognition, and mobility in cognitively impaired persons, Front Cell Dev Biol, 10, 10.3389/fcell.2022.864842

Moutinho, 2017, Therapeutic potential of nuclear receptor agonists in Alzheimer’s disease, J Lipid Res, 58, 1937, 10.1194/jlr.R075556

Urquiza, 2000, Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain, Science, 290, 2140, 10.1126/science.290.5499.2140

Létondor, 2016, EPA/DHA and vitamin A supplementation improves spatial memory and alleviates the age-related decrease in hippocampal RXRγ and kinase expression in rats, Front Aging Neurosci, 8, 103, 10.3389/fnagi.2016.00103

Nock, 2017, Carriers of an apolipoprotein E epsilon 4 allele are more vulnerable to a dietary deficiency in omega-3 fatty acids and cognitive decline, Biochim Biophys Acta Mol Cell Biol Lipids, 1862, 1068, 10.1016/j.bbalip.2017.07.004

Daiello, 2015, Association of fish oil supplement use with preservation of brain volume and cognitive function, Alzheimers Dement, 11, 226, 10.1016/j.jalz.2014.02.005

Coughlan, 2021, APOE ε4 alters associations between docosahexaenoic acid and preclinical markers of Alzheimer’s disease, Brain Commun, 3, fcab085, 10.1093/braincomms/fcab085

Stoub, 2010, Rate of entorhinal and hippocampal atrophy in incipient and mild AD: relation to memory function, Neurobiol Aging, 31, 1089, 10.1016/j.neurobiolaging.2008.08.003

Di Paola, 2007, Episodic memory impairment in patients with Alzheimer’s disease is correlated with entorhinal cortex atrophy: a voxel-based morphometry study, J Neurol, 254, 774, 10.1007/s00415-006-0435-1

Morris, 2016, Association of seafood consumption, brain mercury level, and APOE ε4 status with brain neuropathology in older adults, JAMA, 315, 489, 10.1001/jama.2015.19451

Liao, 2017, Apolipoprotein E metabolism and functions in brain and its role in Alzheimer’s disease, Curr Opin Lipidol, 28, 60, 10.1097/MOL.0000000000000383

Courtney, 2016, LXR regulation of brain cholesterol: from development to disease, Trends Endocrinol Metab, 27, 404, 10.1016/j.tem.2016.03.018

Patrick, 2019, Role of phosphatidylcholine-DHA in preventing APOE4-associated Alzheimer’s disease, FASEB J, 33, 1554, 10.1096/fj.201801412R

Chadaideh, 2021, Host-microbial interactions in the metabolism of different dietary fats, Cell Metab, 33, 857, 10.1016/j.cmet.2021.04.011

Weisgraber, 1990, Apolipoprotein E distribution among human plasma lipoproteins: role of the cysteine-arginine interchange at residue 112, J Lipid Res, 31, 1503, 10.1016/S0022-2275(20)42621-5

Yassine, 2017, DHA brain uptake and APOE4 status: a PET study with [1-11C]-DHA, Alzheimers Res Ther, 9, 1, 10.1186/s13195-017-0250-1

Umhau, 2009, Imaging incorporation of circulating docosahexaenoic acid into the human brain using positron emission tomography, J Lipid Res, 50, 1259, 10.1194/jlr.M800530-JLR200

Solomon, 2021, High-dose triglyceride DHA supplementation increases plasma and cerebrospinal fluid phospholipid DHA species, Alzheimers Dement, 17

Arellanes, 2020, Brain delivery of supplemental docosahexaenoic acid (DHA): a randomized placebo-controlled clinical trial, EBioMedicine, 59, 10.1016/j.ebiom.2020.102883

Yassine, 2016, The effect of APOE genotype on the delivery of DHA to cerebrospinal fluid in Alzheimer’s disease, Alzheimers Res Ther, 8, 1, 10.1186/s13195-016-0194-x

Sweeney, 2018, Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders, Nat Rev Neurol, 14, 133, 10.1038/nrneurol.2017.188

Leikin-Frenkel, 2022, How alpha linolenic acid may sustain blood–brain barrier integrity and boost brain resilience against Alzheimer’s disease, Nutrients, 14, 5091, 10.3390/nu14235091

Montagne, 2020, APOE4 leads to blood–brain barrier dysfunction predicting cognitive decline, Nature, 581, 71, 10.1038/s41586-020-2247-3

Andreone, 2017, Blood-brain barrier permeability is regulated by lipid transport-dependent suppression of caveolae-mediated transcytosis, Neuron, 94

Ouellet, 2009, Diffusion of docosahexaenoic and eicosapentaenoic acids through the blood–brain barrier: an in situ cerebral perfusion study, Neurochem Int, 55, 476, 10.1016/j.neuint.2009.04.018

Nkiliza, 2022, APOE e4 dependent deficits in brain DHA phospholipids and mfsd2a in Alzheimer’s disease patients with severe cerebral amyloid angiopathy, Alzheimers Dement, 18, 10.1002/alz.067434

Abdullah, 2016, P3-124: APOE4 genotype-dependent deficits in DHA containing phospholipids and DHA transporters in the cerebrovasculature of Alzheimer’s disease patients, Alzheimers Dement, 12, 10.1016/j.jalz.2016.06.1782

Heinsinger, 2016, Apolipoprotein E genotype affects size of ApoE complexes in cerebrospinal fluid, J Neuropathol Exp Neurol, 75, 918, 10.1093/jnen/nlw067

Johansson, 2017, Abca1 agonist Cs6253 reverses Apoe4-driven Alzheimer’s disease with concomitant changes in plasma and brain Apoe and Apoj, Arterioscler Thromb Vasc Biol, 37, 10.1161/atvb.37.suppl_1.24

Choi, 2015, The E3 ubiquitin ligase idol controls brain LDL receptor expression, ApoE clearance, and Aβ amyloidosis, Sci Transl Med, 7, 314ra184, 10.1126/scitranslmed.aad1904

Skerrett, 2014, Nuclear receptors in neurodegenerative diseases, Neurobiol Dis, 72, 104, 10.1016/j.nbd.2014.05.019

Tai, 2014, Soluble apoE/Aβ complex: mechanism and therapeutic target for APOE4-induced AD risk, Mol Neurodegener, 9, 2, 10.1186/1750-1326-9-2

Braun, 2006, Intracellular trafficking of recycling apolipoprotein E in Chinese hamster ovary cells, J Lipid Res, 47, 1176, 10.1194/jlr.M500503-JLR200

Asaro, 2020, Apolipoprotein E4 disrupts the neuroprotective action of sortilin in neuronal lipid metabolism and endocannabinoid signaling, Alzheimers Dement, 16, 1248, 10.1002/alz.12121

Rawat, 2019, ApoE4 alters ABCA1 membrane trafficking in astrocytes, J Neurosci, 39, 9611, 10.1523/JNEUROSCI.1400-19.2019

Fan, 2011, An ABCA1-independent pathway for recycling a poorly lipidated 8.1 nm apolipoprotein E particle from glia, J Lipid Res, 52, 1605, 10.1194/jlr.M014365

Zhao, 2017, Apolipoprotein E4 impairs neuronal insulin signaling by trapping insulin receptor in the endosomes, Neuron, 96, 115, 10.1016/j.neuron.2017.09.003

Yassine, 2023, Baseline findings of PreventE4: a double-blind placebo controlled clinical trial testing high dose DHA in APOE4 carriers before the onset of dementia, J Prev Alzheimers Dis, 1

Sugasini, 2019, Enrichment of brain docosahexaenoic acid (DHA) is highly dependent upon the molecular carrier of dietary DHA: Lysophosphatidylcholine is more efficient than either phosphatidylcholine or triacylglycerol, J Nutr Biochem, 74, 10.1016/j.jnutbio.2019.108231